KRMD · Repro Med Systems Inc

-

Please sign in to comment on KRMD

1 Comment

Admin

4 years, 1 month ago

Repro Med Systems, Inc is currently in a long term downtrend where the price is trading 18.9% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.

Repro Med Systems, Inc's total revenue sank by 34.8% to $4M since the same quarter in the previous year.

Its net income has dropped by 895.6% to $-799K since the same quarter in the previous year.

Finally, its free cash flow fell by 345.3% to $-2M since the same quarter in the previous year.

Based on the above factors, Repro Med Systems, Inc gets an overall score of 1/5.

Sector	Healthcare
Industry	Medical Instruments & Supplies
Exchange	NASDAQ
CurrencyCode	USD
ISIN	US7599101026

PE Ratio	None
Market Cap	145M
Target Price	5.5
Beta	0.39
Dividend Yield	None

ABOUT

Repro Med Systems Inc

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

KRMD · Repro Med Systems Inc

-

Repro Med Systems Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Repro Med Systems Inc using a moving average strategy